Corporate Banner
Satellite Banner
Scientific Community
Become a Member | Sign in
Home>News>This Article

The Dotmatics Enterprise Platform is Licensed by Redx Pharma

Published: Thursday, January 31, 2013
Last Updated: Thursday, January 31, 2013
Bookmark and Share
Deployment aids quest to develop new drug candidates.

Dotmatics Limited announced that Redx Pharma have licensed and deployed Dotmatics’ entire suite of scientific informatics solutions. This deployment delivers an integrated system that improves access to data, allows the sharing of information and promotes collaboration across different research groups at Redx. Redx develops new drug candidates across eleven different therapeutic classes using its Redox SwitchTM Platform. The company is undergoing a process of rapid expansion. This constant growth creates a dynamic research environment that requires an informatics platform able to hold increasing amounts of complex and diverse data. In addition, it has to be easy to use and intuitive in order to facilitate the quick and efficient adoption by users. Furthermore, the system has to prevent input errors and it has to be compliant with directives from regulatory authorities.

After extensive testing, the Dotmatics Platform proved to be the most flexible informatics system capable of integrating diverse discovery activities from chemistry to biology. The Dotmatics Platform provides Redx with comprehensive informatics solutions to successfully store, query, manage, visualise and analyse their two hundred families of compounds and all associated data.

Using Studies Notebook, chemists and biologists at Redx easily and securely store their structured and unstructured data in a single web-based system. Scientists are able to access their data faster, aggregate them in a single interface and create custom reports in a productive and efficient manner using Browser. Browser is a scalable and robust query and visualisation tool for biological and chemical datasets alike. Dotmatics’ flagship solution Vortex is a world-class visualisation and analytics platform designed specifically to work with scientific data. Vortex provides scientists at Redx with an out-of the-box filtering, charting, plotting and chemically aware calculations engine, enabling scientists to evaluate large datasets in a rich, intuitive and flexible user interface.

Dotmatics CEO, Stephen Gallagher, PhD, said “We are delighted to be working with such a forward thinking organisation as Redx Pharma and we are looking forward to further collaboration with them as both companies continue to develop and move forward.”

Dr Neil Murray, CEO of Redx Pharma, said: “Redx is a rapidly growing drug discovery and development company that was looking to install a single informatics platform solution that could address our needs as we grow. “We chose Dotmatics as we felt they provided the best balance of flexibility against range of capability.”

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Dr Tom Oldfield Joins Dotmatics as Principal Software Architect
Appointment of renowned technologist strengthens company position in big data analytics and biology.
Wednesday, January 28, 2015
The TDDG Selects Dotmatics Data Management Suite
University of Sussex has selected Dotmatics’ web-based Electronic Laboratory Notebook, Studies Notebook
Monday, January 27, 2014
Dotmatics Teams with Leading Distributor to Launch Life Science Informatics Platform in China
The partnership will make Dotmatics’ versatile informatics platform available to a large new market and will provide local support to Dotmatics’ existing Chinese customer base.
Tuesday, March 05, 2013
Dotmatics Vortex Selected to Boost Drug Discovery Efforts at The University of Leeds
Dotmatics announced that it has deployed Vortex for data analysis and visualisation at the University of Leeds, UK.
Tuesday, February 12, 2013
Dotmatics Informatics Selected to Enhance Research at Moulder Center for Drug Discovery
The Dotmatics platform is an integrated suite of software specifically designed to maximise efficiency in data transfer between research institutes, collaborators and CROs.
Friday, January 25, 2013
Scientific News
Closing the Loop on an HIV Escape Mechanism
Research team finds that protein motions regulate virus infectivity.
World’s First Therapeutic Venom Database
Open-source library describes nearly 43,000 effects on the human body.
Mathematical Model Forecasts the Path of Breast Cancer
Chances of survival depend on which organs breast cancer tumors colonize first.
The Secret Behind the Power of Bacterial Sex
Migration between different communities of bacteria is the key to the type of gene transfer that can lead to the spread of traits such as antibiotic resistance, according to researchers at Oxford University.
Biomedical Imaging at One-Thousandth the Cost
Mathematical modeling enables $100 depth sensor to approximate the measurements of a $100,000 piece of lab equipment.
University of Glasgow Researchers Make An Impact in 60 Seconds
Early-career researchers were invited to submit an engaging, dynamic and compelling 60 second video illuminating an aspect of their research.
On Top of the Flu
Chance for advance warning in search-based tracking method.
TGAC Announces Milestone in Wheat Research
A more complete and accurate wheat genome assembly is being made available to researchers, by The Genome Analysis Centre (TGAC) on 12 November 2015.
Shedding Light on “Dark” Cellular Receptors
UNC and UCSF labs create a new research tool to find homes for two orphan cell-surface receptors, a crucial step toward finding better therapeutics and causes of drug side effects.
Is Allergy the Price We Pay for Our Immunity to Parasites?
New findings help demonstrate the evolutionary basis for allergy.
Scroll Up
Scroll Down

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos